Industry Update: Pharmaceuticals

Industry Highlights

  • On June 2, 2022 Regeneron Pharmaceuticals, Inc. today announced its intent to purchase Sanofi’s stake in the Regeneron and Sanofi collaboration on Libtayo® (cemiplimab), providing Regeneron with exclusive worldwide development,
    commercialization and manufacturing rights to the medicine.

Past Industry Updates

Pharmaceuticals: April 2022

Pharmaceuticals: February 2022

Pharmaceuticals: July 2021

Pharmaceuticals: May 2021

Pharmaceuticals: January 2021

Pharmaceuticals: October 2020

Pharmaceuticals: July 2020

Pharmaceuticals: May 2020

Pharmaceuticals: December 2019

Pharmaceuticals: October 2019

More Industry Reports